Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is on track to lose approximately $7.9 trillion worth of economic activity over the next ten years, regardless of the federal government’s astronomical stimulus spending in order to prop up the economy.

Although many restrictions across the US are being lifted and both consumers and businesses are slowly starting to recover, the financial effects of the coronavirus pandemic are most likely going to be felt well into fiscal 2030. The report estimates that real economic output will be reduced by at least 3% when compared to previous pre-pandemic estimates, meanwhile nominal GDP will see a reduction of 5.3% – which translates to approximately $15.7 trillion.

Furthermore, the CBO is anticipating GDP levels to drop by the most in US history in the second quarter of 2020, while the month of May will have an unemployment rate of approximately 20% – the highest since the Great Depression. As a result, Senator Chuck Schumer is calling on the Senate to approve another round of fiscal stimulus in order to mitigate the impending negative impacts on the economy.

Information for this briefing was found via CNBC and the Congressional Budget Office. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Amid CBS Shuffle, Is Joe Rogan Replacing Anderson Cooper On 60 Minutes?

Silver47 Targets Resource Growth With 10,000 Metre Red Mountain Drill Program

Related News

Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows

Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental...

Thursday, April 23, 2020, 04:16:38 PM

How Long Can The Stock Market Ignore The Economy?

Naturally, as long as it wants. Despite constant assertions to the contrary, the stock market...

Monday, April 20, 2020, 08:20:16 AM

US Banks Bracing for Period After Loan Deferrals Expire

When first quarter earnings were coming out, many US banks realized the true extent of...

Friday, May 22, 2020, 12:00:00 PM

Coronaviral! Market Movers Takes On The Low-Float Pandemic Pops

There’s no panic like a pandemic. Equities markets of all kinds took another tumble Friday...

Saturday, February 29, 2020, 11:37:57 AM

Datametrex Sees Second Sale Of COVID-19 Test Kits To Canadian Mine Operator

Datametrex AI Limited (TSXV: DM) is in the business of recurring sales evidently. The company...

Wednesday, June 24, 2020, 09:00:32 AM